Colorado Springs, COLORADO4 Active Studies

Leukemia Clinical Trials in Colorado Springs, COLORADO

Find 4 actively recruiting leukemia clinical trials in Colorado Springs, COLORADO. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
2,318
Enrolling

Recruiting Leukemia Studies in Colorado Springs

RecruitingColorado Springs, COLORADONCT06077760

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

The goal of this study is to evaluate intismeran autogene plus pembrolizumab versus placebo plus pembrolizumab for the adjuvant treatment of margin negative, completely resected Stage II, IIIA, IIIB (...

868 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingColorado Springs, COLORADONCT06623422

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

The goal of this study is to learn if people who receive intismeran autogene and pembrolizumab after surgery are cancer-free longer than people who receive placebo and pembrolizumab. Researchers want ...

680 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingColorado Springs, COLORADONCT06339008

A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. Participants can expect study participation to last up to...

450 participants
Eli Lilly and Company
View Study Details
RecruitingColorado Springs, COLORADONCT06497556

A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer

The purpose of this study is to assess the safety and efficacy of divarasib compared to locally approved KRAS G12C inhibitors (sotorasib or adagrasib) in participants with KRAS G12C-positive (KRAS G12...

320 participants
Hoffmann-La Roche
View Study Details

About Leukemia Clinical Trials in Colorado Springs

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 4 leukemia clinical trials recruiting participants in Colorado Springs, COLORADO. These studies are seeking a combined 2,318 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Eli Lilly and Company, Hoffmann-La Roche. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Colorado Springs — FAQ

Are there leukemia clinical trials in Colorado Springs?

Yes, there are 4 leukemia clinical trials currently recruiting in Colorado Springs, COLORADO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Colorado Springs?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Colorado Springs research site will contact you about next steps.

Are clinical trials in Colorado Springs free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Colorado Springs studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 4 active trials in Colorado Springs are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated March 2, 2026 from ClinicalTrials.gov